Researcher
Frederik Cleeren
- Disciplines:Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medical imaging and therapy, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Member
From24 Sep 2012 → Today
Projects
1 - 10 of 19
- Development and preclinical evaluation of diagnostic and therapeutic radiopharmaceuticals for pancreatic cancerFrom2 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- '213Bi-188Ready' Improved Theranostics with Bismuth-213 and Rhenium-188From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Generator based therapeutic radiopharmaceutical production for targeting of fibroblast activation protein (FAP)From1 Oct 2023 → TodayFunding: FWO senior postdoctoral fellowship
- A fully automated system for the generation of stained tissue slices for scientific research.From1 Jan 2023 → TodayFunding: BOF - scientific equipment program
- Research on radioactive nuclei at ISOLDE-CERN, SPIRAL2- GANIL and MEDICIS-CERNFrom1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Targeted alpha therapy of pancreatic tumors in a theranostic settingFrom1 Oct 2022 → TodayFunding: BOF - projects, Fund Recuperation Fiscal Exemption
- 161Tb-labeled radiopharmaceuticals targeting mucin receptors for treatment of pancreatic cancerFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- IMAGINATION : IMAGing bIomarkers for diagNosis, therAnosTIcs and drug develOpmeNtFrom1 Oct 2022 → TodayFunding: IOF - mandates
- Development and preclinical evaluation of innovative NANOBODY® based radioprobes for imaging and targeted radionuclide therapy.From12 Aug 2021 → TodayFunding: Baekeland
- Development and preclinical evaluation of diagnostic and therapeutic radiopharmaceuticals targeting CXCR4From10 Aug 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 42
- Terbium radionuclides for theranostic applications in nuclear medicine: from atom to bedside(2024)
Authors: Christophe Deroose, Kristof Baete, Thomas Elias Cocolios, Frederik Cleeren
Pages: 1720 - 1743 - Synthesis and Preclinical Evaluation of PSMA-Targeted 111In-Radioconjugates Containing a Mitochondria-Tropic Triphenylphosphonium Carrier(2023)
Authors: Frederik Cleeren, Irwin Cassells, Simon Leekens, Christopher Cawthorne
Pages: 216 - 233 - Impact on clinical management when using [18F]AlFNOTA-octreotide instead of [68Ga]Ga-DOTA-SSA PET/CT in neuroendocrine tumor patients: preliminary results(2023)
Authors: Jeroen Dekervel, Frederik Cleeren, Michel Koole, Guy Bormans, Chris Verslype, Christophe Deroose
Pages: S508 - S508 - Radiopharmaceuticals for Cancer Imaging and Therapy(2023)
Authors: Guy Bormans, Frederik Cleeren
- Radiochemical and Biological Evaluation of 3p-C-NETA-ePSMA-16, a Promising PSMA-Targeting Agent for Radiotheranostics(2023)
Authors: Stephen Ahenkorah, Frederik Cleeren
- 18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use(2023)
Authors: Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Chris Verslype, Frederik Cleeren, Christophe Deroose
Pages: 835 - 841 - Prospective comparison of [18F]AlF-NOTA-octreotide PET/MRI to [68Ga]Ga-DOTATATE PET/CT in neuroendocrine tumor patients(2023)
Authors: Frederik Cleeren, Jeroen Dekervel, Michel Koole, Guy Bormans, Annouschka Laenen, Paul Clement, Kristiaan Nackaerts, Chris Verslype, Koen Van Laere, Christophe Deroose
- 18F-AlF-NOTA-Octreotide Outperforms 68Ga-DOTATATE/ NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study(2023)
Authors: Elin Pauwels, Frederik Cleeren, Michel Koole, Jeroen Dekervel, Annouschka Laenen, Paul Clement, Chris Verslype, Guy Bormans, Christophe Deroose
Pages: 632 - 638 - Direct comparison of [18F]AlF-NOTA-JR11 and [18F]AlF-NOTA-octreotide for PET imaging of neuroendocrine tumors: Antagonist versus agonist(2023)
Authors: Stephen Ahenkorah, Christopher Cawthorne, Christophe Deroose, Thomas Cardinaels, Guy Bormans, Frederik Cleeren
- Highlight selection of radiochemistry and radiopharmacy developments by editorial board(2023)
Authors: Frederik Cleeren